Northwestern Medicine opened a new Transplant Institute on Tuesday, consolidating four of its existing transplant programs into a single hub backed by about $26 million in philanthropic funding and roughly 300 staff members. The launch comes weeks after Arthur Nichols, a 70-year-old man from West Bloomfield Township, Michigan, whose kidneys were damaged by multiple myeloma, received a kidney from his daughter, Natalie Nichols, in a case Northwestern is holding up as an example of the kind of care the institute is designed to deliver.
The institute brings together four of Northwestern's existing transplant programs, according to the Chicago Sun-Times, and was made possible by a five-year fundraising campaign, according to Northwestern Medicine. The health system says the new structure is home to Illinois' largest liver, kidney and living-donor transplant programs, and it will house specialized centers focused on kidney, liver, pancreas, islet-cell, intestinal and pediatric transplantation, along with centers dedicated to transplant research, access and innovation. The institute was spearheaded by transplant surgeon Dr. Satish N. Nadig, who described its goal as becoming what he called a destination for transplant innovation, per the Chicago Tribune.
The timing lines up with a milestone Northwestern reached roughly a month earlier: its liver transplant team completed its 3,000th liver transplant in September, becoming the first program in Illinois to hit that number, the health system said. Northwestern also performed 691 transplants in 2025, the most in its history, and it ranks among the nation's top 10 transplant centers by transplant volume, according to Northwestern Medicine. Statewide demand remains steep — more than 4,700 people in Illinois were waiting for an organ transplant as of October, most of them for a kidney, per the Sun-Times.
A Father, A Daughter, And A Secret Search For A Donor
Nichols was diagnosed with multiple myeloma, which severely damaged his kidneys, just days before Christmas in 2023. He underwent dialysis, chemotherapy, radiation and a stem cell transplant, with continued dialysis carrying serious health risks. Dr. Nadig has said dialysis shortens a patient's lifespan by a significant percentage each year, the Tribune reported.
After meeting with Northwestern's transplant doctors, Natalie Nichols began seeking potential donor candidates and posted a Facebook appeal, but she kept her own plans to donate quiet so she wouldn't pressure her father, per the Tribune. She and her father underwent the transplant procedure together on Sept. 18 at Northwestern Memorial Hospital. One day later, doctors asked Nichols whether he wanted to meet his donor — and learned it had been his daughter all along, according to the Tribune's reporting.
Nichols recovered swiftly after the surgery. Natalie Nichols told the Tribune she was walking within about three days, and said her father wore a neck brace for almost six months. Northwestern's transplant program has typically run an average hospital stay of about two to three days without newer surgical techniques, per the same reporting.
Betting On Machine Perfusion And AI Matching
Part of the institute's pitch rests on technology meant to stretch what's medically possible before and during transplant surgery. Machine perfusion allows organs to remain alive outside the body for extended periods, giving doctors more time to optimize a patient before the transplant itself, the Tribune reported. Dr. Nadig has used the technique to keep a liver alive for up to 32 hours — far beyond the six-to-eight-hour window other transplant programs around the country typically rely on, according to the Tribune. Northwestern doctors also used machine perfusion to divide a single liver into two parts for two separate recipients, which the Tribune reported was a first for the country.
Separately, Northwestern's liver transplant program has introduced warm and cold machine perfusion to make more donor livers usable and to assess organ quality during transport, according to Northwestern Medicine. The institute is also developing AI-powered donor matching, among other innovations the health system lists that include awake kidney transplantation, robotic surgery, xenotransplantation and regenerative medicine. The Sun-Times reports the institute plans to specifically investigate how artificial intelligence could help match organ recipients with donors.
Trying To Get Patients Off Anti-Rejection Drugs For Good
One of the institute's more ambitious goals involves reducing or eliminating patients' lifelong dependence on anti-rejection medication, which transplant recipients typically take for the rest of their lives. The Tribune reports the institute currently has 37 patients off anti-rejection medication — a figure Dr. Nadig said is more than anywhere else in the world. Northwestern Medicine is pursuing cellular and immune-tolerance approaches aimed at the same goal, according to Northwestern's Breakthroughs for Physicians.
Donor stem-cell treatment has been explored as a way to help kidney recipients stop taking anti-rejection drugs. And more than a decade ago, Chicago kidney recipient Lindsay Porter was reported free of anti-rejection medication less than two years after her own transplant, according to Northwestern's Feinberg School of Medicine.
Building On Six Decades Of Transplant History
Northwestern's Organ Transplant Center dates back to 1964 and is described as one of the largest and longest-running programs of its kind in Illinois, according to Northwestern Medicine's HealthBeat. The center performed its 10,000th abdominal organ transplant in April 2024, becoming the first health system in Illinois to reach that total, and it has run 90 active clinical trials, including some aimed at reducing or eliminating patients' need for antirejection medications, per HealthBeat.
Dr. Nadig has framed the new institute as a way to pool that history with new funding and staff under one roof. He identified patients as the core motivation behind the institute and its technologies, and said the philanthropic funding would support further work and the recruitment of leading transplant researchers nationally and globally, according to the Tribune. He also said the institute aims to lay a foundation for the future of transplant medicine and to shift physician resistance to adopting new approaches, per the same reporting.
For Arthur Nichols, the institute's stated ambitions trace back to a personal choice made inside one Chicago hospital room. His daughter's decision to donate, kept private until the day after surgery, turned a routine post-transplant conversation into the moment he learned who had given him a second chance — a story Northwestern is now folding into its pitch for what transplant care in Chicago could look like next.
